Author

Xin Huang

Wuhan Union HospitalORCID 0000-0002-0413-3340Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xin Huang4 papers · Yale University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Shaojie XuiD· 2 shared Xingyin LiiD· 2 shared Yaying DuiD· 2 shared Youyun PengiD· 2 shared Yuan Su· 2 shared Ang LiiD· 1 shared Christine M. LightiD· 1 shared Guojun Wang· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Shaojie XuORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genome-wide CRISPR/Cas9 knockout screen identifies host factors essential for Bovine Parainfluenza Virus Type 3 replication

Jinyang Hao, Xiaoran Gao, Christine M. Light, Yuze Sun, Sha Lu, Yu Tian, Xia Gao, Yuan Su, Jie Gao, Xin Huang, Qianyi Zhang, Jinliang Wang, Rong Hai, Wei Hu, Guojun Wang

This study uses a genome-wide CRISPR/Cas9 knockout screen in bovine cells to identify host factors essential for BPIV3 replication, revealing SLC35A1 and LSM12 as critical for viral entry.

Science China Life Sciences · Jan 28, 2026Peer-reviewedMicrobiology

Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid Cancer

Shaojie Xu, Xingyin Li, Youyun Peng, Xueping Yang, Yuan Su, Hanning Li, S. Wang, Xin Huang, Xiaodong Li, Yaying Du

This study develops a nanodrug, mPDS@CAR-M, for targeted treatment of RAIR-DTC by combining chemotherapy, photothermal therapy, and tumor cell membrane coating to enhance tumor targeting and therapeutic efficacy.

Biomaterials Research · Jan 1, 2026Peer-reviewedCancer Biology

Biomimetic Cascade-Targeting Drug Delivery System for Reversing Chemoresistance in Osteosarcoma

Xingyin Li, Shaojie Xu, Youyun Peng, Ziliang Su, Sining Wang, Ang Li, Yaying Du, Zengwu Shao, Xin Huang

This paper develops a drug delivery system to overcome chemoresistance in osteosarcoma by combining photothermal therapy and dual drug delivery with targeted nuclear release.

bioRxiv · Nov 4, 2025 · PreprintCancer Biology